Total Payments
$8,623
2024 Payments
$1,622
Companies
15
Transactions
67
Medicare Patients
1,657
Medicare Billing
$224,367
Payment Breakdown by Category
Consulting$5,139 (59.6%)
Other$2,200 (25.5%)
Food & Beverage$1,136 (13.2%)
Education$148.93 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,139 | 6 | 59.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,200 | 6 | 25.5% |
| Food and Beverage | $1,136 | 52 | 13.2% |
| Education | $148.93 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $7,673 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $340.97 | 17 | $0 (2020) |
| NxStage Medical, Inc. | $118.44 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $105.73 | 2 | $0 (2022) |
| Amgen Inc. | $99.44 | 7 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $59.27 | 4 | $0 (2019) |
| Relypsa, Inc. | $58.90 | 3 | $0 (2019) |
| PFIZER INC. | $44.10 | 3 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $29.46 | 2 | $0 (2019) |
| Outset Medical Inc | $21.79 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,622 | 2 | AstraZeneca Pharmaceuticals LP ($1,600) |
| 2023 | $573.20 | 4 | AstraZeneca Pharmaceuticals LP ($454.76) |
| 2022 | $5,551 | 13 | AstraZeneca Pharmaceuticals LP ($5,457) |
| 2021 | $84.99 | 1 | AstraZeneca Pharmaceuticals LP ($84.99) |
| 2020 | $56.06 | 3 | Otsuka America Pharmaceutical, Inc. ($44.23) |
| 2019 | $587.71 | 35 | Otsuka America Pharmaceutical, Inc. ($264.74) |
| 2018 | $148.49 | 9 | OPKO Pharmaceuticals, LLC ($35.58) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Outset Medical Inc | — | Food and Beverage | In-kind items and services | $21.79 | General |
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.76 | General |
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $337.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/09/2023 | NxStage Medical, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $118.44 | General |
| Category: Nephrology | ||||||
| 11/13/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $674.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $674.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $3.78 | General |
| 08/30/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $93.41 | General |
| 08/02/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $36.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $1,011.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $115.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $842.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: NEPHROLOGY | ||||||
| 02/24/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Nephrology | ||||||
| 01/29/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEPHROLOGY | ||||||
| 12/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 329 | 472 | $149,336 | $33,904 |
| 2022 | 8 | 328 | 569 | $165,749 | $49,432 |
| 2021 | 6 | 291 | 539 | $120,197 | $37,325 |
| 2020 | 12 | 709 | 1,282 | $401,064 | $103,706 |
Total Patients
1,657
Total Services
2,862
Medicare Billing
$224,367
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 190 | $48,714 | $11,260 | 23.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 59 | $27,050 | $5,794 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 70 | $22,260 | $4,861 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 46 | $12,324 | $3,617 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 29 | $8,219 | $2,639 | 32.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 26 | 43 | $14,425 | $2,321 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $9,840 | $1,795 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,504 | $1,617 | 24.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 14 | 61 | $45,323 | $13,727 | 30.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 114 | 245 | $44,100 | $13,308 | 30.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 69 | $23,460 | $7,101 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 58 | $12,876 | $4,563 | 35.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 49 | $12,691 | $3,749 | 29.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 33 | 57 | $14,763 | $3,233 | 21.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $7,000 | $2,148 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,536 | $1,605 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 126 | 316 | $56,880 | $17,766 | 31.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 71 | 72 | $24,480 | $7,446 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 37 | $8,180 | $3,737 | 45.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 44 | $11,396 | $3,507 | 30.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 31 | 57 | $14,763 | $3,218 | 21.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,498 | $1,652 | 36.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 243 | 538 | $88,839 | $29,627 | 33.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 33 | 128 | $121,600 | $26,896 | 22.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 102 | 106 | $34,653 | $10,499 | 30.3% |
About Dr. Hunter Huston, MD
Dr. Hunter Huston, MD is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1861751703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hunter Huston, MD has received a total of $8,623 in payments from pharmaceutical and medical device companies, with $1,622 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($5,139).
As a Medicare-enrolled provider, Huston has provided services to 1,657 Medicare beneficiaries, totaling 2,862 services with total Medicare billing of $224,367. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Nashville, TN
- Active Since 05/13/2012
- Last Updated 02/24/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1861751703
Products in Payments
- FARXIGA (Drug) $5,517
- LOKELMA (Drug) $2,134
- JYNARQUE (Drug) $279.77
- LIBERTY SELECT CYCLER (Device) $118.44
- Parsabiv (Biological) $87.61
- SAMSCA (Drug) $61.20
- Rayaldee (Drug) $59.27
- Veltassa (Drug) $58.90
- Velphoro (Drug) $29.46
- CHANTIX (Drug) $23.82
- FABRAZYME (Drug) $20.93
- ELIQUIS (Drug) $20.28
- INJECTAFER (Drug) $16.51
- SOLIRIS (Drug) $12.32
- Parsabiv (Drug) $11.83
- ACTHAR (Biological) $10.97
- CRYSVITA (Drug) $9.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757